Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.70 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.70 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.70 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.70 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.70 |
| ▸ | ACHE | P22303 | 1/20 | 0.70 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.70 |
| ▸ | DRD3 | P35462 | 1/20 | 0.70 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.70 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metamelfalan SCHEMBL6842568 | 1.00 | CYP3A4 (0.70) | CYP3A4ALOX15HIF1APTGS1ALDH1A1 | |
| Metamelfalan SCHEMBL2015272 | 1.00 | CYP3A4 (0.70) | CYP3A4ALOX15HIF1APTGS1ALDH1A1 | |
| Metamelfalan SCHEMBL2015275 | 1.00 | CYP3A4 (0.70) | CYP3A4ALOX15HIF1APTGS1ALDH1A1 | |
| Melphalan SCHEMBL4984726 | 0.84 | HIF1A (0.91) | CYP3A4ALOX15HIF1APTGS1ALDH1A1 | |
| SCHEMBL18427979 | 0.84 | IDO1 (0.57) | CYP3A4ALOX15HIF1APTGS1ALDH1A1 | |
| SCHEMBL19714971 | 0.84 | IDO1 (0.57) | CYP3A4ALOX15HIF1APTGS1ALDH1A1 | |
| SCHEMBL18427948 | 0.84 | IDO1 (0.57) | CYP3A4ALOX15HIF1APTGS1ALDH1A1 | |
| SCHEMBL6843476 | 0.83 | SMN1; SMN2 (0.53) | CYP3A4ALOX15HIF1APTGS1ALDH1A1 | |
| SCHEMBL2778981 | 0.83 | NOS3 (0.56) | CYP3A4ALOX15HIF1APTGS1ALDH1A1 | |
| SCHEMBL2778977 | 0.83 | NOS3 (0.56) | CYP3A4ALOX15HIF1APTGS1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119129212-A | Determination method for reasonable positions of pre-excavated retracting roadway and cutting holes under double left coal pillars | 中国矿业大学 | 2024-12-13 | — | — | CN | claimed |
| CN-117946722-A | Heavy overvaporization oil separation method in vacuum fractionation process | 洛阳瑞华新能源技术发展有限公司 | 2024-04-30 | — | — | CN | claimed |
| US-20260109640-A1 | WINDOW MANUFACTURING DEVICE AND WINDOW MANUFACTURING METHOD USING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2026-04-23 | — | — | US | disclosed |
| US-20260068068-A1 | DISPLAY DEVICE, AND ELECTRONIC DEVICE INCLUDING THE DISPLAY DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2026-03-05 | — | — | US | disclosed |
| US-12296014-B2 | External preparation comprising non-lamellar liquid crystal-forming lipid | FARNEX INCORPORATED (JP) | 2025-05-13 | — | — | US | disclosed |
| CN-119129212-A | Determination method for reasonable positions of pre-excavated retracting roadway and cutting holes under double left coal pillars | 中国矿业大学 | 2024-12-13 | — | — | CN | disclosed |
| EP-3629730-B1 | GROWTH MEDIA COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-12-04 | — | — | EP | disclosed |
| CN-117946722-A | Heavy overvaporization oil separation method in vacuum fractionation process | 洛阳瑞华新能源技术发展有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117467683-A | Recombinant subunit fusion protein vaccine, and preparation method and application thereof | 申联生物医药（上海）股份有限公司 | 2024-01-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12296014-B2 | External preparation comprising non-lamellar liquid crystal-forming lipid | LIPA, LIPC, CETP | CYP3A4 254/4885ALOX15 186/4885HIF1A 4689/4885 |
| US-20260068068-A1 | DISPLAY DEVICE, AND ELECTRONIC DEVICE INCLUDING THE DISPLAY DEVICE | EPHA8, EPHB2, EPHA4 | CYP3A4 3777/4885ALOX15 4428/4885HIF1A 1326/4885 |
| US-20260109640-A1 | WINDOW MANUFACTURING DEVICE AND WINDOW MANUFACTURING METHOD USING THE SAME | KLF10, KLRK1, ZKSCAN2 | CYP3A4 2673/4885ALOX15 3506/4885HIF1A 994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.